SII logo
SII logo
products

PRODUCTS SUPPLIED IN INDIA

Serum - Protection from birth onwards

Sii HibPRO

Haemophilus Type b Conjugate Vaccine I.P.

bacterial siihibpro

INDICATION

Hib Conjugate Vaccine is recommended for prevention of invasive disease caused by Haemophilus Influenze type b for infants and children of 6 weeks through 5 years of age.

ROUTE OF ADMINISTRATION

Subcutaneous or Intramuscular Injection

IMMUNIZATION SCHEDULE

  • For infants 6 weeks to 6 months of age: The immunizing dose is three separate injections of 0.5 ml given at approximately 4 weeks intervals.
  • Previously unvaccinated infants from 7 through 11 months of age should receive two separate injections approximately 2 months apart.
  • Children from 12 through 14 months of age who have not been vaccinated previously received one injection.
  • All vaccinated children receive a single booster dose at 12- 18 months of age, but not less than 2 months after the previous dose.
  • Previously unvaccinated children 15 to 60 months of age receive a single injection of haemophilus influenzae type b conjugate vaccine.
  • Preterm infants should be vaccinated according to their chronological age, from birth.

COMPOSITION

  • Each single 0.5 ml dose contains
  • Purified capsular polysaccharide (PRP) 10 mcg
  • Tetanus Toxoid (carrier protein) 19 to 33 mcg
  • Diluent: Reconstitute with diluents for Haemophilus Type b Conjugate vaccine B.P.
PRESENTATION:
Box of 1 dose vial with 0.5 ml diluent